Person: DUMAN, NİLGÜN
6 results
Search Results
Now showing 1 - 6 of 6
Publication Follow up four cerebrotendinous xanthomatosis patients importance of early diagnosis and treatment.(2017-05-30) DUMAN, NİLGÜN; AKYÜZ, ENES; GEÇKİNLİ, BİLGEN BİLGE; ZUBARİOĞLU, T; YEŞİL, GÖZDE; DUMAN, NİLGÜN; AKYÜZ, ENES; YEŞİL, GÖZDEPublication EPİLEPSİ , HİPOTONİ VE DİSMORFİK ÖZELLİKLER İLE PREZENTEOLAN DE NOVO İNTERSTİSYEL 4P DELESYONU(2018-11-11T00:00:00Z) Duman, Nilgün; YARARBAŞ, KANAY; Sayar, Ceyhan; Özciğer, Derya; İÇAĞASIOĞLU, DİLARA FÜSUN; DUMAN, NİLGÜN; İÇAĞASIOĞLU, DİLARA FÜSUNPublication Co-occurrence of interrupted aortic arch and Apert syndrome: A case report.(2021-01-01T00:00:00Z) Ergor, SERAP NUR; Duman, Nilgun; Kutuk, Mehmet Serdar; Yozgat, Can Yilmaz; Temur, Hafize Otcu; Ugurlucan, Murat; Yozgat, Yilmaz; ERGÖR, SERAP NUR; DUMAN, NİLGÜN; YOZGAT, YILMAZPublication COVID-19 vaccine candidates and vaccine development platforms available worldwide(2021-12-01T00:00:00Z) DUMAN, NİLGÜN; ALzaidi, Zahraa; Aynekin, Busra; Taskin, Duygu; Demirors, Busra; YILDIRIM, ABDULBAKİ; Sahin, Izem Olcay; BİLGİLİ, FAİK; TAHİR TURANLI, EDA; Beccari, Tommaso; Bertelli, Matteo; Dundar, Munis; DUMAN, NİLGÜNThe pandemic caused by the worldwide spread of the coronavirus, which first appeared in 2019, has been named coronavirus disease 19 (COVID-19). More than 4.5 million deaths have been recorded due to the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to the World Health Organization. COVID-19 Dashboard in September 2021. Apart from the wildtype, other variations have been successfully transmitted early in the outbreak although they were not discovered until March 2020. Modifications in the SARS-CoV-2 genetic material, such as mutation and recombination, have the ability to modify the viral life span, along with transitivity, cellular tropism, and symptom severity. Several processes are involved in introducing novel vaccines to the population, including vaccine manufacturing, preclinical studies, Food and Drug Administration permission or certification, processing, and marketing. COVID-19 vaccine candidates have been developed by a number of public and private groups employing a variety of strategies, such as RNA, DNA, protein, and viral vectored vaccines. This comprehensive review, which included the most subsequent evidence on unique features of SARS-CoV-2 and the associated morbidity and mortality, was carried out using a systematic search of recent online databases in order to generate useful knowledge about the COVID-19 updated versions and their consequences on the disease symptoms and vaccine development.Publication Yeni mutasyon saptanan hipofosfatemik raşitizm olgusu(2017-04-30) KUTLU, ESRA; ÖZGEN, İLKER TOLGA; CESUR, YAŞAR; DUMAN, NİLGÜN; KUTLU, ESRA; ÖZGEN, İLKER TOLGA; CESUR, YAŞAR; DUMAN, NİLGÜNPublication Normokalsemik seyreden psödohipoparatiroidi tip 1A(2016-10-09) ÖZGEN, İLKER TOLGA; KUTLU, ESRA; YEŞİL, GÖZDE; CESUR, YAŞAR; DUMAN, NİLGÜN; ÖZGEN, İLKER TOLGA; KUTLU, ESRA; YEŞİL, GÖZDE; CESUR, YAŞAR; DUMAN, NİLGÜN